BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences, a company of Roche, announces that researchers from Bielefeld University in Germany have used a single sequencing run, generated during the installation of their new Genome Sequencer FLX System, to completely assemble and characterize the genome of Corynebacterium kroppenstedtii. The whole genome analysis, led by Andreas Tauch, revealed that lipophilism is the dominant feature involved in pathogenicity of the corynebacterium. The study1, entitled “Ultrafast pyrosequencing of Corynebacterium kroppenstedtii DSM44385 revealed insights into the physiology of a lipophilic corynebacterium that lacks mycolic acids” appears in the Journal of Biotechnology.
